Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;57(1):83-92.
doi: 10.1007/s00125-013-3080-0. Epub 2013 Oct 19.

Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study

Affiliations

Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study

Carlos Lorenzo et al. Diabetologia. 2014 Jan.

Abstract

Aims/hypothesis: White cell count has been shown to predict incident type 2 diabetes, but differential white cell count has received scant attention. We examined the risk of developing diabetes associated with differential white cell count and neutrophil:lymphocyte ratio and the effect of insulin sensitivity and subclinical inflammation on white cell associations.

Methods: Incident diabetes was ascertained in 866 participants aged 40-69 years in the Insulin Resistance Atherosclerosis Study after a 5 year follow-up period. The insulin sensitivity index (SI) was measured by the frequently sampled IVGTT.

Results: C-reactive protein was directly and independently associated with neutrophil (p < 0.001) and monocyte counts (p < 0.01) and neutrophil:lymphocyte ratio (p < 0.001), whereas SI was inversely and independently related to lymphocyte count (p < 0.05). There were 138 (15.9%) incident cases of diabetes. Demographically adjusted ORs for incident diabetes, comparing the top and bottom tertiles of white cell (1.80 [95% CI 1.10, 2.92]), neutrophil (1.67 [1.04, 2.71]) and lymphocyte counts (2.30 [1.41, 3.76]), were statistically significant. No association was demonstrated for monocyte count (1.18 [0.73, 1.90]) or neutrophil:lymphocyte ratio (0.89 [0.55, 1.45]). White cell and neutrophil associations were no longer significant after further adjusting for family history of diabetes, fasting glucose and smoking, but the OR comparing the top and bottom tertiles of lymphocyte count remained significant (1.96 [1.13, 3.37]). This last relationship was better explained by SI rather than C-reactive protein.

Conclusions/interpretation: A lymphocyte association with incident diabetes, which was the strongest association among the major white cell types, was partially explained by insulin sensitivity rather than subclinical inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between 5 year risk of type 2 diabetes and total white cell count and subfractions modelled by a smooth function. The relationship was linear for all cell types (Wald for linearity, p>0.3) and statistically significant for (a) white cell count (p value of the Wald χ2=0.028) and (b) lymphocyte count (p=0.004). (c) Neutrophil count (p=0.161) and (d) monocyte count (p=0.600) were not associated with incident diabetes. Results were adjusted for age, sex, race/ethnicity and clinic
Figure 2
Figure 2
Heterogeneity analyses for the relationship of white cell and lymphocyte counts to the 5 year incidence of diabetes. Results adjusted for aage, sex, race/ethnicity and clinic; bage, race/ethnicity and clinic; cage, sex and clinic; and dage, sex and race/ethnicity

Similar articles

Cited by

References

    1. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107. - PubMed
    1. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–1830. - PMC - PubMed
    1. Wu H, Ghosh S, Perrard XD, et al. T cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007;115:1029–1038. - PubMed
    1. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356:1517–1526. - PubMed
    1. Goldfine AB, Fonseca V, Jablonski KA, et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med. 2013;159:1–12. - PMC - PubMed

Publication types

Substances